ArticleNeuroimage. Reports2026
Early diagnosis of Alzheimer's disease based on brain morphological changes: A comprehensive approach combining voxel-based morphometry and deep learning.
Article in Neuroimage. Reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Emerging diagnostic biomarkers and therapeutic targets in Alzheimer's disease.Inflammopharmacology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Deep learning algorithms optimize data by enhancing resolution and suppressing noise associated with biological knowledge. The root issue is that, for example, CNNs learning mathematical patterns from statistical correlations in the data without regard to biological cues whatsoever, and merely apply filters such as max pooling, never grasping what the biological cues they are supposed to investigate are. This blind procedure can indeed be in technical language; however, it does not help to identify meaningful insights into neuroimaging, where interpretability is essential, and such inadequacies pose a grave challenge. In our research, rather than depending on the CNNs and FCNs only for the feature extractions, we have integrated biologically motivated features into voxel-based morphometry as well as deep learning. Our goal is to analyze T1-weighted MRI scans and T2-Flair images to investigate the characteristics of gray matter, white matter, cerebrospinal fluid, and white matter Hyperintensity in patients with mild cognitive impairment (MCI) who lie on the spectrum between normal aging and Alzheimer's disease (AD). So we extracted critical structural features such as white matter Hyperintensity, gray matter volume, white matter volume, cerebrospinal fluid (CSF) volume, and cortical thickness. These are biologically meaningful biomarkers that reflect the neurodegenerative alterations directly. To validate our method, after the detection of biological features, we have converted them into 3-bit, 4-bit, 8-bit, and 16-bit images. These images were used as inputs for both FCN and CNN models to investigate the early symptoms of AD from classified intracranial features.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.